COVID-19 Blog Feed
Below is a feed from our blogs showing the latest posts related to COVID-19. We update our blogs regularly and invite you to explore, participate and subscribe using the RSS button.

COVID-19 Feed
posted on Fri, 03 Apr 2020
The U.S. Department of Labor has just issued over one hundred pages of detailed temporary regulations, effective from April 1, 2020 to December 31, 2020, implementing the Families First Coronavirus Response Act (“FFCRA”). The regulations provide much-needed clarity on a range of issues that many employers have struggled with over the past week. Below is... Continue Reading…
posted on Fri, 03 Apr 2020
On March 27, 2020, the President signed into law the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), the third phase of emergency relief passed by Congress in response to the coronavirus pandemic. The CARES Act includes relief measures for workers and employers that impact employee benefit and compensation arrangements, and which may... Continue Reading…
posted on Fri, 03 Apr 2020
As we have written about here and on our sister blog, Ad Law Access, regulators have wasted no time in taking enforcement actions against companies’ alleged false marketing around COVID-19. Just today, the Office of the New York Attorney General (“NYAG”) sent a cease and desist letter to CBD company Finest Herbalist for marketing through... Continue Reading
posted on Fri, 03 Apr 2020
Legal hemp businesses suffering from the economic devastation caused by coronavirus are eligible for emergency aid programs included in the $2.2 trillion federal economic stimulus package – and can start applying for that monetary relief immediately. While medical and recreational marijuana companies will not be able to benefit from the coronavirus stimulus package because marijuana... Continue Reading
posted on Thu, 02 Apr 2020
On March 27, 2020, the President signed the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) into law.  The CARES Act’s purpose is aimed at reducing the economic impact of the COVID-19 pandemic and stimulating the economy with a $2.1 trillion dollar infusion. Among other things, the CARES Act amends Section 7(a) of the Small... Continue Reading…
posted on Thu, 02 Apr 2020
In the midst of continued enforcement regarding coronavirus marketing, FDA sent a warning letter to NeuroXPF concerning advertising for its CBD products alleging that they can boost immune systems to help consumers avoid contracting the virus. Citing the need to take “urgent measures to protect consumers” in the midst of the coronavirus outbreak, FDA advised... Continue Reading
posted on Thu, 02 Apr 2020
In the midst of continued enforcement regarding coronavirus marketing, FDA sent a warning letter to NeuroXPF concerning advertising for its CBD products alleging that they can boost immune systems to help consumers avoid contracting the virus. Citing the need to take “urgent measures to protect consumers” in the midst of the coronavirus outbreak, FDA advised... Continue Reading
posted on Thu, 02 Apr 2020
On April 1, 2020, the Department of Labor (“DOL”) posted a temporary rule issuing regulations for implementing the Families First Coronavirus Response Act (“FFCRA”), which became effective the same day. We reported on the DOL’s other recent efforts to flesh out the new law through its FAQ section, which included some much needed guidance on what... Continue Reading…
posted on Wed, 01 Apr 2020
Last week, the Coronavirus Aid, Relief, and Economic Security (CARES) Act was signed into law, implementing broad relief for individuals and businesses affected by COVID-19.  One of the sections of the CARES Act receiving less attention is a temporary amendment to the Bankruptcy Code to provide streamlined reorganization procedures for businesses with debt of less... Continue Reading
posted on Wed, 01 Apr 2020
FDA took action earlier this week to relax regulatory standards for gowns, hoods, and surgeons’ and patient examination gloves during the pandemic.  The policy applies to the following products: Table 1 Classification Regulation Device Type Product Code6 Class 21 CFR 878.4040 Conductive Shoe and Shoe Cover BWP I (exempt) 21 CFR 878.4040 Operating-Room Shoes FXW... Continue Reading
Displaying results 1-10 (of 40)
 |<  < 1 - 2 - 3 - 4  >  >|